Acumen Pharmaceuticals Inc (ABOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 329 | 730 | 151 | 226 | 0 |
| Gross Profit | 329 | 730 | 151 | 226 | N/A |
| Operating Expenses | 1,670 | 3,220 | 2,186 | 2,272 | 0 |
| Operating Income | -1,341 | -2,490 | -2,035 | -2,046 | N/A |
| Other Income | 586 | 0 | 0 | 1 | 0 |
| Pre-tax Income | -755 | -2,490 | -2,035 | -2,045 | 0 |
| Net Income Continuous | -755 | -2,490 | -2,035 | -2,045 | N/A |
| Net Income | $-755 | $-2,490 | $-2,035 | $-2,045 | $N/A |
| EPS Basic Total Ops | -1.80 | -5.94 | -4.86 | -4.88 | N/A |
| EPS Basic Continuous Ops | -1.80 | -5.94 | -4.86 | -4.88 | N/A |
| EPS Diluted Total Ops | -1.80 | -5.94 | -4.86 | -4.88 | N/A |
| EPS Diluted Continuous Ops | -1.80 | -5.94 | -4.86 | -4.88 | N/A |
| EBITDA(a) | $-1,341 | $-2,490 | $-2,035 | $-2,046 | $N/A |